GENERATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES AGAINST MULTIPLE EPITOPES ON THE C-TERMINAL HALF OF ENVELOPE GP46 OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I (HTLV-I)

被引:41
作者
TANAKA, Y
YASUMOTO, M
NYUNOYA, H
OGURA, T
KIKUCHI, M
SHIMOTOHNO, K
SHIRAKI, H
KURODA, N
SHIDA, H
TOZAWA, H
机构
[1] NATL CANC CTR,RES INST,DIV VIROL,TOKYO 104,JAPAN
[2] NATL CANC CTR,RES INST,DIV BIOCHEM,TOKYO 104,JAPAN
[3] TOKUYAMA SODA CO LTD,TSUKUBA RES LABS,TSUKUBA,IBARAKI,JAPAN
[4] FUKUOKA RED CROSS BLOOD CTR,CHIKUSHINIO,FUKUOKA,JAPAN
[5] KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN
关键词
D O I
10.1002/ijc.2910460421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to study the antigenicity of envelope 46 kDa glycoprotein (gp46) of human T‐cell leukemia virus type‐l (HTLV‐I), we have generated monoclonal anti‐gp46 antibodies (MAbs), REY‐7, REY‐11, REY‐16, REY‐30, MET‐2 and MET‐3 from rats and mice. Immunoblot and immunofluorescence assays showed that these MAbs recognize gp46 and its related antigens, and specifically stained HTLV‐I‐bearing cells. All MAbs reacted with a recombinant gp46 antigen, NI47, expressing the 147 amino acids in the C‐terminal half of gp46. By using various synthetic peptides corresponding to the gp46 sequence, epitopes recognized by REY‐7 and MET‐3, REY‐11 and RE Y‐16, and REY‐30 were mapped to regions corresponding to the amino acids 175‐199, 253‐282 and 288‐312, respectively. MET‐2 did not react with any of the peptides used. These results indicate that the present MAbs are directed against at least 4 distinct epitopes expressed on the C‐terminal half of gp46. The binding of these MAbs to gp46 was specifically inhibited by sera from HTLV‐I‐infected individuals, but none of these MAbs inhibited the cell fusion activity of HTLV‐I. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:675 / 681
页数:7
相关论文
共 46 条
[21]   IDENTIFICATION AND INITIAL CHARACTERIZATION OF A RAT MONOCLONAL-ANTIBODY REACTIVE WITH THE MURINE INTERLEUKIN-2 RECEPTOR LIGAND COMPLEX [J].
MALEK, TR ;
ROBB, RJ ;
SHEVACH, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5694-5698
[22]  
MANSON DY, 1982, J HISTOCHEM CYTOCHEM, V30, P1114
[23]   HUMAN MONOCLONAL-ANTIBODY DIRECTED AGAINST AN ENVELOPE GLYCOPROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I [J].
MATSUSHITA, S ;
ROBERTGUROFF, M ;
TREPEL, J ;
COSSMAN, J ;
MITSUYA, H ;
BRODER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2672-2676
[24]  
MINOWADA J, 1972, J NATL CANCER I, V49, P891
[25]   NEW SYNTHETIC ROUTE TO TERT-BUTYLOXYCARBONYLAMINOACYL-4-(OXYMETHYL)PHENYLACETAMIDOMETHYL-RESIN, AN IMPROVED SUPPORT FOR SOLID-PHASE PEPTIDE-SYNTHESIS [J].
MITCHELL, AR ;
KENT, SBH ;
ENGELHARD, M ;
MERRIFIELD, RB .
JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (14) :2845-2852
[26]  
MIYOSHI I, 1981, GANN, V72, P978
[27]   HUMAN B-CELL, T-CELL AND NULL-CELL LEUKEMIC CELL LINES DERIVED FROM ACUTE LYMPHOBLASTIC LEUKEMIAS [J].
MIYOSHI, I ;
HIRAKI, S ;
TSUBOTA, T ;
KUBONISHI, I ;
MATSUDA, Y ;
NAKAYAMA, T ;
KISHIMOTO, H ;
KIMURA, I .
NATURE, 1977, 267 (5614) :843-844
[28]   2 E-ROSETTE-FORMING LYMPHOID-CELL LINES [J].
MORIKAWA, S ;
TATSUMI, E ;
BABA, M ;
HARADA, T ;
YASUHIRA, K .
INTERNATIONAL JOURNAL OF CANCER, 1978, 21 (02) :166-170
[29]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I - INDUCTION OF SYNCYTIA AND INHIBITION BY PATIENTS SERA [J].
NAGY, K ;
CLAPHAM, P ;
CHEINGSONGPOPOV, R ;
WEISS, RA .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (03) :321-328
[30]   PROTECTION OF CYNOMOLGUS MONKEYS AGAINST INFECTION BY HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I BY IMMUNIZATION WITH VIRAL ENV GENE-PRODUCTS PRODUCED IN ESCHERICHIA-COLI [J].
NAKAMURA, H ;
HAYAMI, M ;
OHTA, Y ;
ISHIKAWA, K ;
TSUJIMOTO, H ;
KIYOKAWA, T ;
YOSHIDA, M ;
SASAGAWA, A ;
HONJO, S .
INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) :403-407